Description

Clinical Evidence

• GHK-Cu: In vitro studies published in The Journal of Investigative Dermatology and FASEB Journal demonstrate collagen upregulation and dermal tightening effects.
• BPC-157: Animal studies show it accelerates angiogenesis, wound closure, and tendon healing without adverse scar tissue formation.
• TB-500: Known for cytoskeletal reorganization and improved cell migration, facilitating recovery in muscle, tendon, and epithelial tissue.
• A combination of these peptides is being explored for synergistic enhancement of soft tissue healing, particularly in aesthetic and musculoskeletal research.
This blend may be especially valuable in conjunction with microneedling, laser resurfacing, or post-surgical tissue regeneration protocols (for research use only).

Potential Side Effects

In controlled research environments, this peptide combination has shown strong tolerability. Mild and transient effects may include:
• Temporary redness or irritation at the application site
• Mild tingling or warmth during application
• Rare: localized swelling or sensitivity in subjects with hypersensitivity
All three peptides have exhibited favorable safety profiles in preclinical trials.

Disclaimer

The Glow Peptide is intended for laboratory research use only. It is not approved for human use, cosmetic application, or therapeutic intervention. All data cited refer to preclinical or investigational findings. Use by qualified professionals only in licensed research settings.